Gene · 8805
Papers1,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis. | Mol Oncol | 2025 | 40411304 | PubTator, text mining | PubMed |
| Artesunate Enhances Sensitivity of Renal Cancer Cells to Sunitnib by Mediating Tripartite Motif Containing 24-Induced Ubiquitination of Paired Box 6. | Chem Biol Drug Des | 2025 | 40346910 | PubTator, text mining | PubMed |
| Identification of RING E3 pseudoligases in the TRIM protein family. | Nat Commun | 2025 | 40216791 | PubTator, text mining | PubMed |
| Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma. | Cell Death Discov | 2025 | 40097385 | PubTator, text mining | PubMed |
| Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies. | J Biol Chem | 2025 | 40023399 | PubTator, text mining | PubMed |
| A rare intersection: squamous cell carcinoma of the tonsil and the anti-TIF1 syndrome masquerade. | BMC Rheumatol | 2025 | 39865286 | PubTator, text mining | PubMed |
| TRIM24/ZFX affects the stemness and resistance to 5-FU of colorectal cancer cells. | J Chemother | 2025 | 39221698 | PubTator, text mining | PubMed |
| LC-MS-based quantitation of proteomic changes induced by Norcantharidin in MTB-Treated macrophages. | Proteome Sci | 2024 | 39633431 | PubTator, text mining | PubMed |
| The Immune Modulatory Role of TIF1 Proteins. | Adv Exp Med Biol | 2024 | 39546137 | PubTator, text mining | PubMed |
| Targeted protein degradation: advances in drug discovery and clinical practice. | Signal Transduct Target Ther | 2024 | 39500878 | PubTator, text mining | PubMed |
| Retraction Notice to: LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24. | Mol Ther Nucleic Acids | 2024 | 39310881 | PubTator, text mining | PubMed |
| TRIM24-DTNBP1-ATP7A mediated astrocyte cuproptosis in cognition and memory dysfunction caused by Y2O3 NPs. | Sci Total Environ | 2024 | 39304169 | PubTator, text mining | PubMed |
| Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues. | Front Immunol | 2024 | 39281689 | PubTator, text mining | PubMed |
| Clinical and laboratory features between anti-TIF1γ dermatomyositis with and without malignancy: 37 case series and a review. | J Dermatol | 2024 | 39258818 | PubTator, text mining | PubMed |
| APIR: Aggregating Universal Proteomics Database Search Algorithms for Peptide Identification with FDR Control. | Genomics Proteomics Bioinformatics | 2024 | 39198030 | PubTator, text mining | PubMed |
| RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation. | Cancer Sci | 2024 | 39166827 | PubTator, text mining | PubMed |
| The tripartite motif-containing 24 is a multifunctional player in human cancer. | Cell Biosci | 2024 | 39160596 | PubTator, text mining | PubMed |
| Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy. | Mol Neurodegener | 2024 | 39152475 | PubTator, text mining | PubMed |
| Gliotoxin triggers cell death through multifaceted targeting of cancer-inducing genes in breast cancer therapy. | Comput Biol Chem | 2024 | 39146703 | PubTator, text mining | PubMed |
| TRIM24 Cooperates with Ras Mutation to Drive Glioma Progression through snoRNA Recruitment of PHAX and DNA-PKcs. | Adv Sci (Weinh) | 2024 | 38828688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8805/papers?page=4